Drug Interaction Study to Assess the Effect of Co-Administered Miravirsen and Telaprevir in Healthy Subjects

Completed · Phase 1

Conditions studied: Hepatitis C, Chronic Hepatitis C

In brief

The purpose of this study is to assess the safety, tolerability, and affect on blood levels of miravirsen and telaprevir when administered together.

Key facts

Study ID

NCT01646489

Run by

Santaris Pharma A/S

People needed

5

Starts

2012-06-01

Expected to finish

2012-09-01

Last updated by the study team

2012-11-12

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy volunteers
• Weight ≤ 85 kg
• Females of non-childbearing potential (postmenopausal or surgically sterile) or males who are surgically sterile or using an acceptable form of birth control

You may not qualify if…

• Current, clinically significant illness or medical condition

Where it is running

• Spaulding Clinical Research — West Bend, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.